Aurinia Pharmaceuticals Inc. (TSE:AUP), a biopharma stock, moved up after announcing successful Phase IIb study results
Sean Mason | September 30, 2016 | SmallCapPower
Achieving primary and secondary endpoints boosted a small biopharma stock Friday. Here’s some small stocks making big moves on Friday, September 30, 2016 (as of 4 pm EST):
Biopharma stock Aurinia Pharmaceuticals Inc. (TSE:AUP) jumped 14% to $3.95 on Friday after announcing that in addition to voclosporin achieving its primary endpoint of Complete Remission at 24 weeks, both doses of voclosporin when added to the current standard of care of Mycophenolate Mofetil and a forced oral corticosteroid taper have met all 24-week pre-specified secondary endpoints vs the control group in its Phase IIb AURA-LV Study for Lupus Nephritis.
As well, shares of Gray Rock Resources Ltd. (CVE:GRK) gained 38% to $0.11 as the mineral exploration company said it has entered into a binding letter agreement with DeCoors Mining Corp. to acquire the Surprise Lake Property in British Columbia, consisting of 32 mineral claims and covering an area of 5,144 hectares, in return for 4.0 million Gray Rock common shares. The Surprise Lake Property covers two documented mineral occurrences on file with the British Columbia Geological Survey and the recent discovery in July, 2016, of visible gold in bedrock along Otter Creek.
Sage Gold Inc. (CVE:SGX), meanwhile, reported that it has executed a binding Term Sheet with Cartesian Royalty Holdings Pte Ltd. to provide the Company with a financing package of C$11.5 million to fund the development and restart of Sage Gold’s Clavos gold project in northern Ontario. Sage Gold stock popped 30% to $0.15 following the announcement.
Finally, EnerDynamic Hybrid Technologies Corp. (CVE:EHT) shares rose 5% to $0.105 after the company announced that its wholly-owned subsidiary, Enerdynamic Hybrid Technologies Inc., has supplied PowerStream, one of Ontario’s largest electricity distribution companies, a solar powered carport charging unit for testing at their facility in Barrie, Ontario.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
